CORE LABORATORIES N V Quarterly Deferred Tax Assets, Net of Valuation Allowance in USD from Q4 2010 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Core Laboratories N V quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q4 2010 to Q4 2022.
  • Core Laboratories N V Deferred Tax Assets, Net of Valuation Allowance for the quarter ending December 31, 2022 was $77M, a 2.55% decline year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $77M -$2.02M -2.55% Dec 31, 2022 10-K 2023-02-10
Q4 2021 $79M -$5.89M -6.93% Dec 31, 2021 10-K 2023-02-10
Q4 2020 $84.9M +$3.8M +4.68% Dec 31, 2020 10-K 2022-02-10
Q4 2019 $81.1M +$59.9M +282% Dec 31, 2019 10-K 2021-02-08
Q4 2018 $21.2M -$4M -15.8% Dec 31, 2018 10-K 2020-02-10
Q4 2017 $25.2M -$10.1M -28.7% Dec 31, 2017 10-K 2019-02-11
Q4 2016 $35.4M +$2.76M +8.47% Dec 31, 2016 10-K 2018-02-12
Q4 2015 $32.6M +$9.92M +43.7% Dec 31, 2015 10-K 2017-02-10
Q4 2014 $22.7M +$9.3M +69.4% Dec 31, 2014 10-K 2016-02-12
Q4 2013 $13.4M -$7.86M -37% Dec 31, 2013 10-K 2015-02-17
Q4 2012 $21.2M -$2.9M -12% Dec 31, 2012 10-K 2014-02-13
Q4 2011 $24.1M +$359K +1.51% Dec 31, 2011 10-K 2013-02-19
Q4 2010 $23.8M Dec 31, 2010 10-K 2012-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.